Clinical Trials Logo

Pruritus clinical trials

View clinical trials related to Pruritus.

Filter by:

NCT ID: NCT06366659 Not yet recruiting - Clinical trials for Intrahepatic Cholestasis of Pregnancy

Unraveling the Pathogenesis of Pruritus in Intrahepatic Cholestasis of Pregnancy

Start date: April 20, 2024
Phase:
Study type: Observational

This study hopes identify the main pruritogens of ICP pruritus and provide new insights for the diagnosis, prediction, and treatment of ICP. Details are as follows: It is planned to include ICP confirmed pregnant women and healthy pregnant women who have given birth in the Peking University Third Hospital and Sichuan University West China Second University Hospital. Then progesterone sulfate levels in plasma samples will be quantified by High Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS) and itch intensity will be quantified by questionnaires. Main study endpoint: To reveal new indicators of ICP diagnosis with high accuracy: single, multiple or combined indicators of progesterone sulfates and other molecules like bile acids; Secondary study endpoint: To determine whether progesterone sulfates can be used as an early screening indicator for ICP for disease prediction, specifically whether elevated levels of progesterone sulfates predate pruritus in pregnant women with ICP.

NCT ID: NCT06334679 Recruiting - Burns Clinical Trials

The Effect of Cold Gel Pack Application on Itching in Burn Patients in the Maturation Stage

Start date: January 15, 2024
Phase: N/A
Study type: Interventional

Burn is a serious trauma that causes acute damage to the skin and subcutaneous tissues due to the effect of heat, electricity, radiation, physical, and chemical substances. It has been reported that the incidence of itching is high in burn patients during the maturation stage of wound healing. The literature suggests that in managing the symptom of itching, skin hydration support along with cold application methods can also be used. The integrity of the skin, the duration, frequency, characteristics, areas of itching, and identifying conditions that increase or decrease itching are important for managing itching. This study is planned to be conducted with a randomized controlled design to examine the effect of applying cold gel packs to burn areas of burn patients during the maturation stage on itching. This researcher's hypothesis is that burn patients who applied cold gel packs to burn areas during the maturation phase had lower itching severity (frequency, duration, intensity) than those who did not.

NCT ID: NCT06297499 Not yet recruiting - Clinical trials for Pruritus Caused by Drug

Ondansetron Use for Preventing Pruritus In Patients Undergoing Cesarean Section

Start date: March 2024
Phase: Phase 1
Study type: Interventional

Opioids are often added with a local anesthetic to enhance the duration and quality of spinal anesthesia for cesarean delivery patients. However, spinal opioids are associated with a wide variety of side effects such as nausea, vomiting, (N/V) and pruritus (itching). The occurrence of pruritus can vary between 30% and 100% making pruritus the most common side-effect of intrathecal opioids and this rate is even higher in pregnant patients. Pruritus may require treatment which can be ineffective or sometimes reverse the analgesic effect of the opioids. Ondansetron is a safe and very commonly used Serotonin receptor antagonist treatment for local anesthetic opioid-induced pruritus used in pregnancy. The effect of different administration times of ondansetron in reducing pruritus or N/V in cesarean section (CS) cases has not been extensively studied and thus, this prospective study can help guide future clinical management of side effects caused by spinal intrathecal morphine administration.

NCT ID: NCT06290375 Not yet recruiting - Pruritus Clinical Trials

A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.

Start date: March 8, 2024
Phase: Phase 2
Study type: Interventional

This is a two- stage study. Stage I is a multicenter, open-label trial;Stage II was a multi-center, randomized, double-blind, placebo-controlled trial. About 250 maintenance peritoneal dialysis patients with moderate or above pruritus are planned to be enrolled.

NCT ID: NCT06262607 Recruiting - Clinical trials for Chronic Pruritus in Adult Subjects With Notalgia Paresthetica (NP)

A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica

Start date: January 29, 2024
Phase: Phase 2
Study type: Interventional

This is a Phase 2, randomized, double-blind, vehicle-controlled study to assess the efficacy and safety of CLE-400 topical gel for the treatment of chronic pruritus in adult subjects with Notalgia Paresthetica (NP).

NCT ID: NCT06243120 Not yet recruiting - Clinical trials for Pruritus Caused by Drug

Intravenous Lidocaine for Treating Intrathecal Fentanyl Induced Pruritus

Start date: March 1, 2024
Phase: Early Phase 1
Study type: Interventional

The study will assess efficacy of intravenous lidocaine 1 mg/kg diluted with 0.9% sodium chloride to a volume of 100 ml to suppress intrathecal fentanyl induced pruritus. This will be compared to control group who will receive 100 ml normal saline as placebo. The main outcome is regression of initial VAS score with incidence of pruritus.

NCT ID: NCT06226610 Not yet recruiting - Pruritis Clinical Trials

Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic

Start date: February 1, 2024
Phase: Phase 2
Study type: Interventional

The goal of this study is to test the efficacy of Dupixent in improving post-burn itching symptoms versus the current standard of care.

NCT ID: NCT06225323 Recruiting - Cesarean Section Clinical Trials

Effect of Lidocaine Infusion on Neuraxial Opioid-induced Pruritus After Cesarean Section

Start date: January 29, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to assess the efficacy and potency of lidocaine infusion as a preventive measure on pruritus response after injection of 200 micro gram morphine with bupivacaine subarachnoid block, spinal anesthesia, in cesarean section.

NCT ID: NCT06190132 Completed - Clinical trials for Uremic Pruritus in Hemodialysis Patients

The Effect of Omega-3 Fatty Acids Versus Gabapentin in Uremic Pruritus in Hemodialysis Patients

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

omega-3 fatty acids versus gabapentin in uremic pruritus in hemodialysis patients.

NCT ID: NCT06188546 Not yet recruiting - Clinical trials for Pruritus Caused by Drug

Propofol for Prophylaxis of Morphine Induced Pruritis in Caesarean Section

Start date: January 1, 2024
Phase: Phase 3
Study type: Interventional

the goal of this randomized clinical trial is to find the optimum sub hypnotic dose of iv propofol that prevents the incidence of itching induced from intrathecal morphine used in spinal anesthesia in caesarean section operation. the main questions it aim to answer are the number of patients complained of pruritus in the first 24 hours post operative period and the severity of the pruritus. participants will be divided into 4 groups. 1st group receives 0 mg of propofol , 2nd receives 10 mg , 3rd receives 20 mg and the 4th receives 30 mg.